{"id":"W2024548912","doi":"10.1002/cncr.27674","title":"Phase 3, randomized, placebo‐controlled study of zibotentan (ZD4054) in patients with castration‐resistant prostate cancer metastatic to bone","year":2012,"lang":"en","type":"article","venue":"Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Placebo; Clinical endpoint; Hazard ratio; Peripheral edema; Internal medicine; Adverse effect; Bone pain; Randomized controlled trial; Common Terminology Criteria for Adverse Events; Population; Cancer; Surgery; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001318456,0.00120631,0.002449094,0.0004035942,0.0004438334,0.0008039729,0.000853403,0.001204294,0.006427603],"category_scores_gemma":[0.001324461,0.0005848383,0.001176453,0.0004236488,0.0007421899,0.0006248558,0.0002801717,0.002013432,0.0008302713],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007368494,"about_ca_system_score_gemma":0.001444318,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001244379,"about_ca_topic_score_gemma":0.003181097,"domain_scores_codex":[0.9995694,0.0002177259,0.00002174388,0.00007005737,0.00004917221,0.000072003],"domain_scores_gemma":[0.9993964,0.000147671,0.0001662643,0.00003779371,0.00005024048,0.0002015319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9646218,0.01096905,0.0009596132,0.000614252,0.0009190809,0.00005260797,0.00005486978,0.0003632263,0.006354305,0.00009938724,0.0009911724,0.01400046],"study_design_scores_gemma":[0.9510674,0.04605362,0.001743638,0.00001192364,0.0001842852,0.00002278199,0.00001070221,0.0002338306,0.000226535,0.00004881306,0.0003899225,0.000006483572],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9827768,0.00394205,0.0009887236,0.0006437758,0.0005950858,0.00754763,0.001490965,0.0001642651,0.00185072],"genre_scores_gemma":[0.9831852,0.002519181,0.001609292,0.001380137,0.0003721873,0.007117942,0.001338263,0.00002269239,0.002454986],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006427603,"threshold_uncertainty_score":0.02150249,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02518159830858788,"score_gpt":0.3572338929697615,"score_spread":0.3320522946611736,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}